List of Tables
Table 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Adding An Anti-Androgen
Table 4. Key Players of Stopping An Anti-Androgen
Table 5. Key Players of Estrogens
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Others
Table 9. Global Castration Resistant Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2018-2023)
Table 13. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Castration Resistant Prostate Cancer Treatment Market Share by Region (2024-2029)
Table 15. Castration Resistant Prostate Cancer Treatment Market Trends
Table 16. Castration Resistant Prostate Cancer Treatment Market Drivers
Table 17. Castration Resistant Prostate Cancer Treatment Market Challenges
Table 18. Castration Resistant Prostate Cancer Treatment Market Restraints
Table 19. Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 20. Global Castration Resistant Prostate Cancer Treatment Market Share by Players (2018-2023)
Table 21. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2022)
Table 22. Ranking of Global Top Castration Resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2022
Table 23. Global 5 Largest Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service
Table 26. Date of Enter into Castration Resistant Prostate Cancer Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 29. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2018-2023)
Table 30. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2024-2029)
Table 32. Global Castration Resistant Prostate Cancer Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 33. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2018-2023)
Table 34. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2024-2029)
Table 36. North America Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 43. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 44. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 45. Latin America Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 47. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 48. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 49. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 50. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 51. Active Biotech Company Detail
Table 52. Active Biotech Business Overview
Table 53. Active Biotech Castration Resistant Prostate Cancer Treatment Product
Table 54. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 55. Active Biotech Recent Development
Table 56. Diagnocure Company Detail
Table 57. Diagnocure Business Overview
Table 58. Diagnocure Castration Resistant Prostate Cancer Treatment Product
Table 59. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 60. Diagnocure Recent Development
Table 61. Glaxosmithkline Company Detail
Table 62. Glaxosmithkline Business Overview
Table 63. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product
Table 64. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 65. Glaxosmithkline Recent Development
Table 66. Northwest Biotherapeutics Company Detail
Table 67. Northwest Biotherapeutics Business Overview
Table 68. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product
Table 69. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 70. Northwest Biotherapeutics Recent Development
Table 71. Millennium Pharmaceuticals Company Detail
Table 72. Millennium Pharmaceuticals Business Overview
Table 73. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 74. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 75. Millennium Pharmaceuticals Recent Development
Table 76. Hologic Company Detail
Table 77. Hologic Business Overview
Table 78. Hologic Castration Resistant Prostate Cancer Treatment Product
Table 79. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 80. Hologic Recent Development
Table 81. Spectrum Pharmaceuticals Company Detail
Table 82. Spectrum Pharmaceuticals Business Overview
Table 83. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 84. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 85. Spectrum Pharmaceuticals Recent Development
Table 86. Abbott Laboratories Company Detail
Table 87. Abbott Laboratories Business Overview
Table 88. Abbott Laboratories Castration Resistant Prostate Cancer Treatment Product
Table 89. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 90. Abbott Laboratories Recent Development
Table 91. Bayer Healthcare Pharmaceuticals Company Detail
Table 92. Bayer Healthcare Pharmaceuticals Business Overview
Table 93. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 94. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2018-2023) & (US$ Million)
Table 95. Bayer Healthcare Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Castration Resistant Prostate Cancer Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Castration Resistant Prostate Cancer Treatment Market Share by Type: 2022 VS 2029
Figure 3. Hormonal Therapy Features
Figure 4. Adding An Anti-Androgen Features
Figure 5. Stopping An Anti-Androgen Features
Figure 6. Estrogens Features
Figure 7. Chemotherapy Features
Figure 8. Radiation Therapy Features
Figure 9. Others Features
Figure 10. Global Castration Resistant Prostate Cancer Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 11. Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2022 VS 2029
Figure 12. Hospital Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Castration Resistant Prostate Cancer Treatment Report Years Considered
Figure 15. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Castration Resistant Prostate Cancer Treatment Market Share by Region: 2022 VS 2029
Figure 18. Global Castration Resistant Prostate Cancer Treatment Market Share by Players in 2022
Figure 19. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue in 2022
Figure 21. North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Castration Resistant Prostate Cancer Treatment Market Share by Country (2018-2029)
Figure 23. United States Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Castration Resistant Prostate Cancer Treatment Market Share by Country (2018-2029)
Figure 27. Germany Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Region (2018-2029)
Figure 35. China Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Country (2018-2029)
Figure 43. Mexico Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Country (2018-2029)
Figure 47. Turkey Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 50. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 51. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 52. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 53. Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 54. Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 55. Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 56. Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 57. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed